Genetic Assessment of the Patients With Metabolic Syndrome (GENMetS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01268696
Recruitment Status : Unknown
Verified December 2010 by Medical Universtity of Lodz.
Recruitment status was:  Active, not recruiting
First Posted : December 31, 2010
Last Update Posted : July 22, 2011
Information provided by:
Medical Universtity of Lodz

December 28, 2010
December 31, 2010
July 22, 2011
December 2010
August 2011   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01268696 on Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Genetic Assessment of the Patients With Metabolic Syndrome
Genetic Assessment of the Patients With Metabolic Syndrome in Polish Population

Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular disease and diabetes. The exact mechanisms of the complex pathways of metabolic syndrome are not yet completely known. The pathophysiology is extremely complex and has been only partially elucidated. Most patients are older, obese, sedentary, and have a degree of insulin resistance. Stress can also be a contributing factor. The most important factors are:

weight, genetics, aging, sedentary lifestyle,excess caloric intake. In our study we will assess the role of some polymorphisms in the pathology of metabolic syndrome.

Eligibility criteria to the study:

  • patients with metabolic syndrome
  • with written consent
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
the blood samples taken into EDTA
Probability Sample
Patients with metabolic syndrome
Metabolic Syndrome
Not Provided
  • control group
    healthy volunteers
  • Metabolic group
    Patients with metabolic syndrome
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Unknown status
Same as current
January 2015
August 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients with metabolic syndrome according to IDF,AHA and NHLBI 2009

Exclusion Criteria:

  • diabetes type 1
  • cancer
  • not consent
  • steroid therapy
  • alcohol or drug abuse
  • chronic inflammatory disease
  • pregnancy or lactation
  • severe hypothyroidism
  • immunosuppressive treatment
  • operation or severe injury during the last month
Sexes Eligible for Study: All
18 Years to 80 Years   (Adult, Older Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Department of Medical Biotechnology, Medical University of Lodz
Medical Universtity of Lodz
Not Provided
Study Chair: Tadeusz Pietrucha, prof. Department of medical biotechnology
Medical Universtity of Lodz
December 2010